Search results for: pharmaceuticals for children act

Refine your Search
Apply several filters to get precise search results
Showing opportunity 1 - 10 of 42
  • A--Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)

    Type : Bid Notification

    Due : 18 Jan, 2024 (3 months ago)
    Posted : 3 months ago
    Started : 03 Jan, 2024 (3 months ago)

    Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)

    From: Federal Government (Federal)

  • Best Pharmaceuticals for Children Act � Pediatric Trials Network

    Type : Bid Notification

    Due : 18 Dec, 2017 (about 6 years ago)
    Posted : about 6 years ago
    Started : 20 Oct, 2017 (about 6 years ago)

    Although the primary focus of this Contract is to support the Best Pharmaceuticals for Children Act-Pediatric Trials Network clinical activities, NICHD also anticipates the need to utilize this Contract to acquire similar types of support for other NICHD pediatric drug development activities.BPCA 2017 authorizes NICHD to identify therapeutic gaps in pediatrics, which are pediatric diseases, disorders or conditions where more complete knowledge and

    From: Federal Government (Federal)

  • Best Pharmaceuticals for Children Act (BPCA) Data Coordinating Center (DCC)

    Type : Bid Notification

    Due : N/A
    Posted : about 7 years ago
    Started : 05 Dec, 2016 (about 7 years ago)

    for the pediatric clinical trials, and select preclinical data conducted under the authority of the Best Pharmaceuticals for Children Act (BPCA).

    From: Federal Government (Federal)

  • Access to Inpatient Hospital Drug Utilization Data

    Type : Bid Notification

    Due : 11 Feb, 2020 (about 4 years ago)
    Posted : about 4 years ago
    Started : 31 Jan, 2020 (about 4 years ago)

    Access to these data also increase the FDA’s ability to request regulatory impact studies such as those authorized under Best Pharmaceuticals for Children Act (BPCA) and Pediatric Research Equity Act (PREA) to better understand the usefulness of drug labeling to clinicians. This can be done by examining actual use of products in hospitals in relation to recommended labeling.

    From: Federal Government (Federal)

  • COVID-19 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) PILOT PROJECT

    Type : Pre-Bid Notification

    Due : 23 Sep, 2021 (about 2 years ago)
    Posted : about 2 years ago
    Started : 09 Sep, 2021 (about 2 years ago)

    (MIS-C) Data Platform Pilot project – COVID-19 Related Action that is currently being performed under the Best Pharmaceuticals for Children Act (BPCA) Data Coordinating Center (DCC) existing contract with EMMES Corporation, Inc., Rockville, MD.The EMMES Company, LLC currently serves as the DCC for the BPCA Clinical program and provides data coordinating and management services in support of ongoing BPCA Phase 1-3 pediatric clinical trial activities

    From: Federal Government (Federal)

  • Specialty Pharmaceuticals

    Type : Bid Notification

    Due : 30 Jun, 2024 (in 2 months)
    Posted : about 7 years ago
    Started : 23 May, 2013 (about 11 years ago)

    Header InformationBid Number: S153412-vCurrent Description: Specialty Pharmaceuticals Bid Opening Date: 06/30/2024 12:00:00 PM Purchaser: Mary Beth Curley Organization: Department of Public Health Department: 1031CONVD - Default Data Conversion Department Location: 1031L - Default Data Conversion Location Fiscal Year: 13 Type Code: NS - Non-Statewide Solicitation Allow Electronic Quote: No Alternate Id: 306624 Required Date: Available Date : 05/

    From: Massachusetts (State)

  • Specialty Pharmaceuticals

    Type : Bid Notification

    Due : 30 Jun, 2024 (in 2 months)
    Posted : about 6 years ago
    Started : 23 May, 2013 (about 11 years ago)

    Converted bid item. See attachment section for complete bid information.

    From: Massachusetts (State)